Pediatric autoimmune diseases: Kawasaki disease, juvenile dermatomyositis and juvenile localized scleroderma
Shamma Alzaabi, MBBS (she/her/hers)
BC Children's hospital
Vancouver, BC, Canada
Disclosure information not submitted.
Santiago Arciniegas, MSc
The Hospital for Sick Children
Toronto, ON, Canada
Disclosure information not submitted.
Ivan Foeldvari, MD (he/him/his)
Hamburger Zentrum für Kinder- und Jugendrheumatologie
Hamburg, Germany
Disclosure(s): Novartis: Consultant (Ongoing)
Daniel Glaser, MD (he/him/his)
Yale University School of Medicine
New Haven, CT, United States
Disclosure(s): No financial relationships with ineligible companies to disclose
Matthew Sherman, MD, MHS
DAIT/NIAID/NIH
Washington, DC, United States
Disclosure information not submitted.
William Soulsby, III, MD
University of California, San Francisco
San Francisco, CA, United States
Disclosure information not submitted.
Abstract oral session.
Non-CME
Presenting Author: Daniel Glaser, MD (he/him/his) – Yale University School of Medicine
Presenting Author: Matthew Sherman, MD, MHS – DAIT/NIAID/NIH
Presenting Author: Ivan Foeldvari, MD (he/him/his) – Hamburger Zentrum für Kinder- und Jugendrheumatologie
Presenting Author: William Soulsby, III, MD – University of California, San Francisco
Presenting Author: Santiago Arciniegas, MSc – The Hospital for Sick Children
Presenting Author: Shamma Alzaabi, MBBS (she/her/hers) – BC Children's hospital